Fielder Capital Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Fielder Capital Group's BMY Position: Q3 2026 in Review
Fielder Capital Group reduced its Bristol-Myers Squibb (BMY) stake by 8.7% in Q3 2026, selling an estimated $29.3K and leaving 4,868 shares worth $304K. The position accounts for 0.06% of the portfolio, ranked #212.
Fielder Capital Group first reported a position in BMY in Q4 2025 and has held it in 4 quarters since. The position peaked at $455K in Q1 2026. 2,567 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Fielder Capital Group held 4,868 shares of Bristol-Myers Squibb worth $304K as of Q3 2026.
- Fielder Capital Group sold 464 Bristol-Myers Squibb shares in Q3 2026, an estimated $29.3K.
- Bristol-Myers Squibb made up 0.06% of Fielder Capital Group's portfolio in Q3 2026, its #212 holding.
- Fielder Capital Group first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 4 quarters since.
- Fielder Capital Group's Bristol-Myers Squibb position peaked at $455K in Q1 2026.
- 2,567 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Fielder Capital Group's 13F filing for Q3 2026, filed 12 Nov 2026.